Dr. Scott is a Professor in the Department of Pathology at Stanford University and Director of the Stanford Medicine Clinical Genomics Laboratory, where he oversees genomic test innovation and implementation. Dr. Scott is certified by the American Board of Medical Genetics and Genomics (ABMGG) in both Clinical Molecular Genetics and Genomics, and Clinical Cytogenetics and Genomics, and his translational research interests include human genomics, pharmacogenomics, cytogenomics, long-read sequencing, and the implementation of genomic medicine. Dr. Scott is on the steering committees of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Pharmacogene Variation (PharmVar) Consortium, and is an invited member of the Association for Molecular Pathology (AMP) Pharmacogenomics Working Group, International Union of Basic and Clinical Pharmacology (IUPHAR), and other national consortia on genomic medicine, including ClinGen, eMERGE, IGNITE, UDN, and GREGoR. He has co-authored several CPIC practice guidelines and has published over 150 peer-reviewed manuscripts and book chapters on clinical genomics, pharmacogenomics, and genomic medicine implementation. He is the co-editor of the 2nd edition of Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, and is an invited Scientific Editor of the Medical Genetics Summaries (MGS) from the NCBI/NIH/NLM. In addition, Dr. Scott's notable honors include the 2011 William Bowes Jr Award in Medical Genetics from Partners HealthCare Center for Personalized Genetic Medicine, Harvard Medical School, and the 2012 Dr. Harold and Golden Lamport Research Award from the Icahn School of Medicine at Mount Sinai.